Advances in surgery-related adjuvant therapy of intrahepatic cholangiocarcinoma / 国际外科学杂志

ABSTRACT

Intrahepatic cholangiocarcinoma (ICC) has a poor prognosis. Surgical treatment combined with adjuvant therapy including chemotherapy, radiotherapy, molecular targeted drug therapy, local liver damage therapy, interventional therapy, antiviral therapy can have complementary effects to prevent its recurrence after surgery. We will review the latest advances in surgery and adjuvant therapy for ICC, and provide new ideas for the comprehensive treatment and clinical research of ICC.